Alpha Cubed Cuts CME Group Stake 2.6% While Deutsche Bank Raises Target to $318

CMECME

Alpha Cubed Investments LLC trimmed its CME Group stake by 2.6%, selling 2,416 shares and reducing holdings to 91,667 shares valued at $24.8 million. Meanwhile, Norges Bank initiated a $1.57 billion position, Vanguard increased its stake by 532,549 shares, and analysts’ consensus target is $292.18.

1. Alpha Cubed Investments LLC Reduces CME Stake

Alpha Cubed Investments LLC trimmed its position in CME Group Inc. by 2.6% during the third quarter, selling 2,416 shares and ending the period with 91,667 shares valued at approximately $24.8 million. This sale reduced CME’s weighting in Alpha Cubed’s portfolio to 0.9%, making it its 28th largest holding. Over the past year, CME’s shares have traded in a range from $233.12 to $291.76, with the stock currently yielding 1.7% on an annualized dividend of $5.00 per share.

2. Institutional Activity and Ownership Trends

During the same quarter, several major institutional investors adjusted their CME holdings. Norges Bank initiated a new position worth $1.57 billion, Viking Global Investors added $164.6 million, and Magellan Asset Management Ltd expanded its stake by 131,625%, acquiring 486,067 shares valued at $134 million. Overall, institutional ownership stands at 87.75%, reflecting continued confidence in CME’s diversified derivatives and clearing businesses across interest rates, commodities, and equity index products.

3. Analyst Ratings, Dividend Policy, and Insider Transactions

Analysts maintain a consensus "Hold" rating on CME with a $292.18 average target price. Deutsche Bank recently upgraded to "Buy" with a $318 target, while Goldman Sachs reiterated a "Sell" stance at $264. Meanwhile, CEO Terrence A. Duffy sold 25,000 shares at an average price of $269.55 in mid-December, reducing his stake by 27.5%, and the company declared a quarterly cash dividend of $1.25 per share (ex-dividend December 12) representing a 48.5% payout ratio. These developments highlight management’s capital return focus and the range of near-term valuation views among sell-side firms.

Sources

DBZ